SCHEMBL2349672

SCHEMBL2349672

CC(C)(C)N(C(=O)O)C(CO)(CO)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
CYP3A4 P08684 3/20 0.43
CYP2C19 P33261 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP2C9 P11712 1/20 0.43
LMNA P02545 4/20 0.42
CYP2D6 P10635 2/20 0.42
HIF1A Q16665 2/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
SCN1A P35498 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN3A Q9NY46 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
RIPK1 Q13546 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3595900 0.83 MEN1 (0.43) MEN1KMT2ACYP3A4CYP2C19ALDH1A1
SCHEMBL2023058 0.83 MEN1 (0.43) MEN1KMT2ACYP3A4CYP2C19ALDH1A1
SCHEMBL14778273 0.78
SCHEMBL2025505 0.75 MEN1 (0.45) MEN1KMT2ACYP3A4CYP2C19ALDH1A1
SCHEMBL2212129 0.75 CYP3A4 (0.43) MEN1KMT2ACYP3A4CYP2C19ALDH1A1
SCHEMBL2026162 0.75 MEN1 (0.45) MEN1KMT2ACYP3A4CYP2C19ALDH1A1
SCHEMBL19384865 0.74 TRPA1 (0.42) MEN1KMT2ACYP3A4CYP2C19ALDH1A1
SCHEMBL17363044 0.72 MEN1 (0.30) MEN1KMT2ARIPK1
SCHEMBL17028981 0.72 LMNA (0.44) MEN1KMT2AALDH1A1HTTL3MBTL1
SCHEMBL2211148 0.72 MMP8 (0.40) MEN1KMT2ACYP3A4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008315-B2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease Merck, Sharp & Dohme Corp. (US) 2011-08-30 US disclosed
US-7829597-B2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease Merck, Sharp & Dohme, Inc. (US) 2010-11-09 US disclosed